| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 14.09.2011 (4771
dage). |
| Historik | Start | Stop |
|---|
| NORMAL | 14.09.2011 | |
| UNDER FRIVILLIG LIKVIDATION | 28.05.2010 | 13.09.2011 |
| NORMAL | 06.07.2009 | 27.05.2010 |
| Branche | | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
| Sidst opdateret den 16.03.2012 og
angivet som gældende fra 01.01.2012 (4662
dage). |
| Historik | Start | Stop |
|---|
| Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2012 | |
| Uoplyst (999999) | 06.07.2009 | 31.12.2011 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 06.07.2009 (5571
dage). |
Ingen historik.
| Revisor | | KPMG P/S |
| Sidst opdateret den 09.05.2016 og
angivet som gældende fra 20.04.2016 (3091
dage). |
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Pharmanovia A/S. |
| Sidst opdateret den 24.06.2021 og
angivet som gældende fra 16.06.2021 (1208
dage). |
| Historik | Start | Stop |
|---|
| Pharmanovia A/S | 16.06.2021 | |
| Atnahs Pharma Nordics A/S | 18.06.2020 | 15.06.2021 |
| PHARMANOVIA A/S | 21.05.2013 | 17.06.2020 |
| NORDMEDICA INTERNATIONAL A/S | 14.09.2011 | 20.05.2013 |
| NMAS A/S | 06.07.2009 | 13.09.2011 |
| Binavne | | Atnahs Pharma Nordics A/S. |
| Sidst opdateret den 24.06.2021 og
angivet som gældende fra 24.06.2021 (1200
dage). |
| Historik | Start | Stop |
|---|
| Atnahs Pharma Nordics A/S | 24.06.2021 | |
| Pharmanovia Nordic A/S | 24.06.2021 | |
| Pharmanovia Nordics A/S | 24.06.2021 | |
| NORDMEDICA INTERNATIONAL A/S | 06.07.2009 | |
| Pharmanovia A/S | 19.06.2020 | 23.06.2021 |
| PHARMANOVIA A/S | 06.07.2009 | 21.05.2013 |
| Tegningsregel | | Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene. |
| Sidst opdateret den 15.10.2019 og
angivet som gældende fra 15.10.2019 (1818
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | bestyrelsesmedlemmer_hver_for_sig |
| 1 direktør |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene | 15.10.2019 | |
| Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer
i forening | 24.10.2018 | 14.10.2019 |
| Selskabet tegnes af en direktør i forening med formanden eller af en direktør i forening med næstformanden, eller af 2 medlemmer af bestyrelsen eller af den samlede bestyrelse | 04.04.2016 | 23.10.2018 |
| Selskabet tegnes af en direktør i forening med formanden eller næstformanden, af 2 medlemmer af bestyrelsen eller af den samlede bestyrelse | 21.05.2013 | 03.04.2016 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:KPMG
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:statsaut. revisor
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report.
We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Pharmanovia A/S for the financial year 1 April 2022 – 31 March 2023 comprising income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 March 2023 and of the results of the Company's operations for the financial year 1 April 2022 – 31 March 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review.
Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration